Oncotelic Therapeutics, Inc. (OTLC)

Oncotelic Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	12	15	17	52	19	10
Market Cap Growth	-16.64%	-12.32%	-66.46%	165.83%	90.15%	242.04%
Enterprise Value	25	28	28	60	24	12
PE Ratio	-	-1.92	0.97	-4.52	-1.69	-1.38
PS Ratio	177.00	216.48	-	-	11.13	-
PB Ratio	1.05	1.25	0.89	6.48	1.65	0.60
P/FCF Ratio	-11.94	-11.47	-11.90	-11.62	-6.89	-4.47
P/OCF Ratio	-11.94	-11.47	-11.90	-11.62	-6.89	-4.47
EV/Sales Ratio	364.23	399.43	-	-	13.98	-
EV/EBITDA Ratio	-61.20	-49.50	-5.59	-6.61	-3.37	-2.73
EV/EBIT Ratio	-	-	-5.57	-6.57	-3.21	-2.69
EV/FCF Ratio	-22.01	-21.16	-19.48	-13.52	-8.66	-5.09
Debt / Equity Ratio	1.13	1.07	0.58	1.13	0.46	0.09
Debt / EBITDA Ratio	-28.45	-23.01	-2.22	-0.99	-0.75	-0.35
Debt / FCF Ratio	-10.23	-9.84	-7.75	-2.03	-1.93	-0.66
Quick Ratio	0.01	0.01	0.02	0.04	0.04	0.03
Current Ratio	0.01	0.02	0.02	0.04	0.06	0.04
Asset Turnover	0.00	0.00	0	0	0.07	0
Interest Coverage	-0.71	-0.54	-3.27	-4.56	-3.80	-5.75
Return on Equity (ROE)	-65.79%	-65.15%	91.81%	-143.22%	-97.70%	-43.71%
Return on Assets (ROA)	-25.98%	-26.33%	49.34%	-48.25%	-48.60%	-31.19%
Return on Capital (ROIC)	-26.20%	-2.25%	-120.80%	-53.84%	-44.09%	-23.42%
Earnings Yield	-62.84%	-52.15%	103.10%	-22.11%	-59.34%	-72.48%
FCF Yield	-10.50%	-8.72%	-8.40%	-8.61%	-14.51%	-22.38%
Buyback Yield / Dilution	-1.79%	13.37%	-50.88%	-244.02%	-46.93%	-60.96%
Total Shareholder Return	-1.79%	13.37%	-50.88%	-244.02%	-46.93%	-60.96%

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.